Omeprazole Judgment Appeal

AstraZeneca PLC 05 November 2002 OMEPRAZOLE PATENT LITIGATION - ASTRAZENECA TO APPEAL US COURT'S JUDGMENT RELATING TO KUDCo AND SCHWARZ PHARMA AstraZeneca's initial detailed review of the Court's 11th October 2002 opinion relating to KUDCo and Schwarz Pharma has revealed that the United States District Court, Southern District of New York, made reversible errors in determining key facts and applying the law. AstraZeneca has therefore decided to appeal the portions of the Court's judgment relating to KUDCo and Schwarz Pharma. 5 November 2002 Media Enquiries: Steve Brown, Tel: +44 (0) 207 304 5033 Chris Major, Tel: +44 (0) 207 304 5028 Emily Denney, Tel: +44 (0) 207 304 5034 Rachel Bloom-Baglin, Tel: +1 302 886 7858 Investor Relations: Mina Blair-Robinson, Tel: +44 (0) 207 304 5084 Jonathan Hunt, Tel: +44 (0) 207 304 5087 -Ends- This information is provided by RNS The company news service from the London Stock Exchange

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings